Literature DB >> 18071676

Muscarinic receptor subtypes involved in carbachol-induced contraction of mouse uterine smooth muscle.

Takio Kitazawa1, Ryuichi Hirama, Kozue Masunaga, Tatsuro Nakamura, Koichi Asakawa, Jinshan Cao, Hiroki Teraoka, Toshihiro Unno, Sei-ichi Komori, Masahisa Yamada, Jürgen Wess, Tetsuro Taneike.   

Abstract

Functional muscarinic acetylcholine receptors present in the mouse uterus were characterized by pharmacological and molecular biological studies using control (DDY and wild-type) mice, muscarinic M2 or M3 single receptor knockout (M2KO, M3KO), and M2 and M3 receptor double knockout mice (M2/M3KO). Carbachol (10 nM-100 microM) increased muscle tonus and phasic contractile activity of uterine strips of control mice in a concentration-dependent manner. The maximum carbachol-induced contractions (Emax) differed between cervical and ovarian regions of the uterus. The stage of the estrous cycle had no significant effect on carbachol concentration-response relationships. Tetrodotoxin did not decrease carbachol-induced contractions, but the muscarinic receptor antagonists (11-[[2-[(diethylaminomethyl)-1-piperidinyl]acetyl]-5,11-dihydro-6H-pyrido[2,3-b[2,3-b][1,4]benzodiazepin6-one (AF-DX116), N-[2-[2-[(dipropylamino)methyl]-1-piperidinyl]ethyl]-5,6-dihydro-6-oxo-11H-pyrido[2,3-b][1,4] benzodiazepine-11-carboxamide (AF-DX384), 4-diphenylacetoxy-N-methyl-piperidine(4-DAMP), para-fluoro-hexa hydro-sila-diphenidol (p-F-HHSiD), himbacine, methoctramine, pirenzepine, and tropicamide) inhibited carbachol-induced contractions in a competitive fashion. The pKb values for these muscarinic receptor antagonists correlated well with the known pKi values of these antagonists for the M3 muscarinic receptor. In uterine strips isolated from mice treated with pertussis toxin (100 microg/kg, i.p. for 96 h), Emax values for carbachol were significantly decreased, but effective concentration that caused 50% of Emax values (EC50) remained unchanged. In uterine strips treated with 4-DAMP mustard (30 nM) and AF-DX116 (1 microM), followed by subsequent washout of AF-DX116, neither carbachol nor N,N,N,-trimethyl-4-(2-oxo-1-pyrolidinyl)-2-butyn-1-ammonium iodide (oxotremorine-M) caused any contractile responses. Both M2 and M3 muscarinic receptor messenger RNAs were detected in the mouse uterus via reverse transcription polymerase chain reaction. Carbachol also caused contraction of uterine strips isolated from M2KO mice, but the concentration-response curve was shifted to the right and downward compared with that for the corresponding wild-type mice. On the other hand, uterine strips isolated from M3KO and M2/M3 double KO mice were virtually insensitive to carbachol. In conclusion, although both M2 and M3 muscarinic receptors were expressed in the mouse uterus, carbachol-induced contractile responses were predominantly mediated by the M3 receptor. Activation of M2 receptors alone did not cause uterine contractions; however, M2 receptor activation enhanced M3 receptor-mediated contractions in the mouse uterus.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18071676     DOI: 10.1007/s00210-007-0223-1

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  33 in total

1.  Characterisation of muscarinic receptor subtypes in avian smooth muscle.

Authors:  S Darroch; H R Irving; F J Mitchelson
Journal:  Eur J Pharmacol       Date:  2000-08-18       Impact factor: 4.432

Review 2.  Functional M3 muscarinic acetylcholine receptors in mammalian hearts.

Authors:  Zhiguo Wang; Hong Shi; Huizhen Wang
Journal:  Br J Pharmacol       Date:  2004-05-17       Impact factor: 8.739

3.  Cholinergic stimulation of salivary secretion studied with M1 and M3 muscarinic receptor single- and double-knockout mice.

Authors:  Dinesh Gautam; Thomas S Heard; Yinghong Cui; Georgina Miller; Lanh Bloodworth; Jürgen Wess
Journal:  Mol Pharmacol       Date:  2004-08       Impact factor: 4.436

Review 4.  International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors.

Authors:  M P Caulfield; N J Birdsall
Journal:  Pharmacol Rev       Date:  1998-06       Impact factor: 25.468

Review 5.  The use of irreversible ligands to inactivate receptor subtypes: 4-DAMP mustard and muscarinic receptors in smooth muscle.

Authors:  F J Ehlert; M T Griffin
Journal:  Life Sci       Date:  1998       Impact factor: 5.037

6.  Pregnancy and exogenous steroid treatments modulate the expression of relaxant EP(2) and contractile FP receptors in the rat uterus.

Authors:  Y L Dong; C Yallampalli
Journal:  Biol Reprod       Date:  2000-03       Impact factor: 4.285

7.  Characterization of muscarinic receptors in guinea-pig uterus.

Authors:  H N Doods; K D Willim; H W Boddeke; M Entzeroth
Journal:  Eur J Pharmacol       Date:  1993-12-07       Impact factor: 4.432

8.  Characterization of the muscarinic receptor subtype that mediates the contractile response of acetylcholine in the swine myometrium.

Authors:  T Kitazawa; F Uchiyama; K Hirose; T Taneike
Journal:  Eur J Pharmacol       Date:  1999-02-19       Impact factor: 4.432

9.  Expression of muscarinic and nicotinic acetylcholine receptors in the mouse urothelium.

Authors:  Shirin Zarghooni; Julia Wunsch; Martin Bodenbenner; Dörthe Brüggmann; Sergei A Grando; Ulrich Schwantes; Jürgen Wess; Wolfgang Kummer; Katrin S Lips
Journal:  Life Sci       Date:  2007-02-02       Impact factor: 5.037

10.  Muscarinic receptor knockout mice: role of muscarinic acetylcholine receptors M(2), M(3), and M(4) in carbamylcholine-induced gallbladder contractility.

Authors:  Peter W Stengel; Marlene L Cohen
Journal:  J Pharmacol Exp Ther       Date:  2002-05       Impact factor: 4.030

View more
  12 in total

1.  Preliminary Investigations of the Anti-asthmatic Properties of the Aqueous Extract of Justicia pectoralis (Fresh Cut).

Authors:  C Cameron; A S Jacob; E A Thomas; A S Levy
Journal:  West Indian Med J       Date:  2015-05-04       Impact factor: 0.171

Review 2.  Muscarinic receptors and ligands in cancer.

Authors:  Nirish Shah; Sandeep Khurana; Kunrong Cheng; Jean-Pierre Raufman
Journal:  Am J Physiol Cell Physiol       Date:  2008-11-26       Impact factor: 4.249

3.  CHRM3 is a novel prognostic factor of poor prognosis in patients with endometrial carcinoma.

Authors:  Yahui Wang; Jun Li; Shanyun Wen; Xiaomei Yang; Yanli Zhang; Zhijie Wang; Zhigang Zhang
Journal:  Am J Transl Res       Date:  2015-05-15       Impact factor: 4.060

4.  Impaired M3 and enhanced M2 muscarinic receptor contractile function in a streptozotocin model of mouse diabetic urinary bladder.

Authors:  K J Pak; R S Ostrom; M Matsui; F J Ehlert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-03-27       Impact factor: 3.000

5.  Sodium leak channel, non-selective contributes to the leak current in human myometrial smooth muscle cells from pregnant women.

Authors:  Erin L Reinl; Rafael Cabeza; Ismail A Gregory; Alison G Cahill; Sarah K England
Journal:  Mol Hum Reprod       Date:  2015-07-01       Impact factor: 4.025

6.  Responses of pigeon vestibular hair cells to cholinergic agonists and antagonists.

Authors:  Gang Q Li; Manning J Correia
Journal:  Brain Res       Date:  2010-12-11       Impact factor: 3.252

7.  The guinea pig ileum lacks the direct, high-potency, M(2)-muscarinic, contractile mechanism characteristic of the mouse ileum.

Authors:  Michael T Griffin; Minoru Matsui; Rennolds S Ostrom; Frederick J Ehlert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-07-07       Impact factor: 3.000

Review 8.  Role of Muscarinic Acetylcholine Signaling in Gastrointestinal Cancers.

Authors:  Mitsuru Konishi; Yoku Hayakawa; Kazuhiko Koike
Journal:  Biomedicines       Date:  2019-08-10

Review 9.  Overcoming Obstacles to Targeting Muscarinic Receptor Signaling in Colorectal Cancer.

Authors:  Osman Ali; Mazen Tolaymat; Shien Hu; Guofeng Xie; Jean-Pierre Raufman
Journal:  Int J Mol Sci       Date:  2021-01-13       Impact factor: 5.923

10.  Muscarinic receptor signaling in colon cancer.

Authors:  Erik C Von Rosenvinge; Jean-Pierre Raufman
Journal:  Cancers (Basel)       Date:  2011-03-02       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.